chrisvoncsefalvay/vaers-outcomes huggingface dataset:
As with the 1st 2 covid shots, I was tired and very weak for 3-5 days.  However after the booster, my right leg and right arm were so weak it felt like I had had a stroke.  I was unable to sit up our walk without assistance.  My right leg is always weak from my MS and I use a cane normally but this was so much worse.  My husband had to lift me up from the couch and place me in a wheelchair to go to the bathroom for the first 36 hours after the booster.  The effects slowly wore off and by 7 days later I had resumed almost all of my previous mobility.  By 10 days I was 100% back to my previous normal.
Patient began to complain of pain in his legs and soreness.  He refused to participate in a soccer camp he was enrolled in and instead sat on the sidelines.  He then ate lunch and napped.  When it woke from nap he complained he couldn't walk.  He was encouraged to do so and appeared to not be able to straighten his legs.  This continued throughout the day until he was seen by Dr. on the evening of the 30th.  Dr. confirmed that he was unable to walk properly.
PT DEVELOP 2 SPOT OF RASH THE SIZE OF A COIN ON LEFT SIDE OF FACE 35-45 MINUTES AFTER VACCINATION.
Low grade fever 100.5. Very small "blister" lesion all over body approximately 100 very itchy.
This spontaneous report as received from a Licensed Practical Nurse referring to 4 patient of unknown age and gender. No medical history and concurrent conditions were reported. On unknown dates, the patients were vaccinated with improperly stored VARIVAX (lot # M024683, expiry date: 18-MAY-2018) for prophylaxis. Dosing details and route of administration were not reported. No concomitant medications were reported. No adverse effects were reported. On an unknown date, the vaccine was exposed to temperature of -11.7 °C for 40 hours 28 minutes. Previous temperature excursion was reported to have occurred on an unknown date. This case was reported because of a data logger. No product quality complaint (PQC) was reported. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1708USA006109.
Approx 14 hours after vaccination started having chills, headache, stomach upset and fever of 100.2. Feeling better by 2p. Still febrile (101).
Got covid 4 days after vaccine, severe cough, loss of taste, smell, aches, pain especially in my left side of neck. Went to E.R due to muscle spasms, taking motrin, tylenol. Still have severe neck pain.
breasfeeding mom; breasfeeding mom; Pain at injeciton site; Back pain; This is a spontaneous report from a contactable consumer (patient's husband) via a Pfizer sponsored program. This consumer reported for information for both mother and baby. This is the maternal report. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on May2021 (Batch/Lot number was not reported) as 2nd dose, single for covid-19 immunisation. The patient's medical hisrtory and  concomitant medications were not reported. Reporter stated they were concerned of lack of effect. She received the 2nd dose of the covid vaccine 2 days ago (May2021), she had pain at the injection site, back pain, and she was a breasfeeding mom on May2021. Outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021506631 baby case
This is a spontaneous report from a contactable consumer. A 65-year-old female patient of an unspecified ethnicity started to receive PREVNAR 13, via an unspecified route of administration on12Dec2017 at single dose for immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient developed reactions 14Dec2017. the reactions were her joints and knees got stiff and went through out her body until she couldn't walk without any assistance by her husband or walker, extreme pain on the thumb and shoulder joints as well on the injection site and had trouble sleeping but got better the next few days. Her doctor knows about this though and no medications were given. Last 12Jan, similar symptoms happened again. Wanted to know if there have been similar phenomenon's. The outcome of the events was unknown.
dx: varicella, s/s - vesicular rash on head, neck, trunk, genitals, c/w varicella - duration - 1day
It was given 2 weeks after the 1st dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (It was given 2 weeks after the 1st dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (It was given 2 weeks after the 1st dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (It was given 2 weeks after the 1st dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product information was provided.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-Sep-2021: Possible NNI F/U Received: No new information
This case was reported by a consumer and described the occurrence of unspecified event in an adult female subject who was vaccinated with influenza virus vaccine (Flu vaccine, GlaxoSmithKline) for prophylaxis. A physician or other health care professional has not verified this report. On 31 October 2006 the subject received unspecified dose of Flu vaccine at 0.5 ml with an expiration date of 30 June 2007. In the first week of November 2006, at an unspecified time after vaccination with Flu vaccine, the subject developed "problems" (not specified). At the time of reporting the event was unresolved. No additional information is expected.
Pt recvd 1st dose of vax & 48 hrs later exp severe gastrointestinal upset & a h/a;
Swollen under arm swelling and painful Same arm as the injection site began 24 hours after receiving vaccination (3/21/21) stopped (3/23/2021)
Pt given DTaP in Rt leg and MMR in Lt leg. Mom report child's leg turn red and swollen approx 2-3 hrs post shots given. Child brought to clinic by parent area approx siz eof softball and warm to touch.
patient received second dose 21 days after the first one; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received second dose 21 days after the first one) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received second dose 21 days after the first one). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received second dose 21 days after the first one) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported.  No Treatment details were reported.  Patient received second dose 21 days after the first one   Reporter did not allow further contact
received COVID vaccine first dose on 21Dec2020. 10 days later I was diagnosed with COVID; received COVID vaccine first dose on 21Dec2020. 10 days later I was diagnosed with COVID; dizziness; nausea; vomiting; diarrhea; This is a spontaneous report from a contactable pharmacist (reported for herself). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date: not known), via an unspecified route of administration on 21Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received COVID vaccine first dose on 21Dec2020. 10 days later (31Dec2020), the patient was diagnosed with COVID. Her work cancelled her second COVID vaccine until she was symptom free. The patient asked when she should receive her 2nd COVID vaccine. The patient also had a reaction to the first COVID vaccine (dizziness, nausea, vomiting, diarrhea) about 1.5 hours after getting the vaccine at her work on 21Dec2020. She was worried about having strong reaction to 2nd dose since she actually had COVID. The outcome of the events was unknown.  Information on the batch/lot number has been requested.; Sender's Comments: The subject received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 21Dec2020, and 10 days later she was diagnosed with COVID.  No effect of the suspect vaccine could be reasonably achieved to protect from the targeted infection/disease due to the very short time lag.  Instead, the reported COVID likely represents a pre-existing infection prior to vaccine use.  Further information is needed for full medical assessment.
Initial solicited report received from partner on 05 October 2015 from a consumer in the study. The subject (gender and age were not reported) received a dose of INFLUENZA VACCINE (date of vaccination, site and route of administration and batch number were not reported). Medical history and concomitant therapies details were not reported. The subject had received a dose of vaccination two years ago and got a violent reaction on an unspecified date. The lab data and corrective treatment details were not reported. Relationship to investigational product according to company: not associated. Relationship to investigational product according to reporter: not reported. List of documents held by sender: none.
pt presents to ED with c/o increasing dyspnea and generalized weakness; diagnosed positive for COVID 2 days prior; will receive monoclonal antibodies; hx of pancreatic cancer; pt experienced acute conversion to V Fib with loss of pulse; ACLS performed x approx 45 mins; ROSC eventually achieved; refractory shock with bradycardia requiring meds; family decided to not do any more CPR if became pulseless; pt died in the hospital
Right Arm is red in a  4 inch circle. It is day 3 and is still getting bigger.  It is at injection site. Itching and hot to touch.  Went to family doctor.    Also I feel itchy all over.  Face , arms and feet.
Information has been received from a physician via the internet concerning a male patient with egg allergy. On an unspecified date the patient was vaccinated with a dose of MMR II. The patient developed autism after the MMR II. At the time of the report the patient's outcome was unknown. It was unknown if the patient sought medical attention.  Upon internal review autism was considered to be an other important medical event. No further information is available.
Complained of headache which was uncommon but thought related to 1st day in school. Pick up child at school at 3:15PM and felt really tired, headache (holding head), nausea, slept for a couple of hours and woke up with headache again, very lethargic, gave Motrin. At 12:30AM had fever of 102. Today fever resided and headache before nap.
Information has been received from a registered nurse concerning two patients who on an unspecified date were vaccinated with a dose of PNEUMOVAX (lot #661577/1161X). Subsequently the patients developed cellulitis below the injection site near the forearm after receiving PNEUMOVAX on unspecified dates. The Outcomes were unknown. This is one of several reports from the same source. A lot check was requested. A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Agency and was released. Additional information has been requested.
Patient felt dizziness and giddiness . Onsite EMS was called vitals BP 110/68  97% O2 room air HR 58. Patient Refused Evaluation/Care, Left aginst medical advice.
Patient presented with worsening shortness of breath, cough, fever, and chills. Patient tested positive for Covid-19. Patient received IV steroids, antibiotics and remdesivir. Chest xray showed central opacities, required 2L during hospital stay. Patient passed walk study. Patient discharged home.
pt recv vax 24AUG98 & mumps rt side 15SEP98 rt face, ear pain & swollen parotid gland x 24hr;med given;
45 minutes after injection I experienced numbness in cheeks/face and lip. One hour later experienced sort throat and chills and dizziness. Numbness persisted in face and arms/hands for 3-4 hours.
Onset of tongue tingling about 5 minutes after vaccination, lasted at least 30 minutes while being monitored in post-vaccination area. Symptoms improved prior to discharge but had not entirely resolved. No numbness or visible swelling of limps or tongue. Had same sensation after her first Pfizer dose that lasted several hours before resolving, and no other symptoms.
(R) deltoid with 4 cm by 2.5 cm area of indistinct redness, slightly warm, no tenderness. (L) Subq area with 2.5 cm by 2 cm of redness, slightly warm, no tenderness, no duration either area. Roughly shaped like bandaid.
48 hours after injection the employee stated his lower right side of lip was swollen and right side of lower face felt numb - employee is unsure if he had a little pimple on his lip when this event started - given benadryl and bactrim
Patient woke up the morning after the vaccine was given. Her arm was swollen and hot so she called the drs office. She was told to take advil and ice the arm. By Friday morning she was running a fever and went in to see the dr. The doctor diagnosed her with cellulitis and was treated with antibiotics.
1hr p/vax mom states noticed rash on sides of face along jaw line swelling on face bottom lip;no fever;19AUG96 tc to father took to clinic 16AUG96 MD stated was not r/t vax med given to put on rash;pt ok gone to school;
shingles; pain; UTI infection; joint pain; couldn't sleep; nerve pain; her leg started hurting after the first dose; Her leg is getting worse; rash came out; miserable; This is a spontaneous report received from contactable consumer (patient). A 62-Year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EW0164), via an unspecified route of administration, administrated in Left arm on 29Jul2021 between 4PM - 4:30PM (age at the time of vaccination 62-years-old), as a single dose for COVID-19 immunization. The patient's medical history included UTI. The patient's concomitant medications included Nitrofurantoin (Nitrofurantoin Mono/Mac), 100mg 1 capsule twice a day every 12 hours; Macrobid [Nitrofurantoin], for UTI infection; and Cefdinir 300mg from 14Aug2021. On an unspecified date Aug2021, 2 weeks and 10 days later the patient experienced shingles, pain, UTI infection, joint pain, couldn't sleep, nerve pain, her leg started hurting after the first dose, her leg is getting worse, rash came out, and miserable. On 16Aug2021, the patient underwent lab tests and procedures which included Ultrasound for blood clot: Negative. Patient received treatment as a result of adverse events. Patient visited to emergency room as a result of adverse event. The doctor looked at it, and prescriber her medication, which she took called Valtrex. The reason she went to the doctor is because her stomach was killing her, she thought she was constipated or there was a blockage, she didn't feel good, the doctor checked her urine saw there was an UTI, because she had high White Blood Cell count, then they gave the Nitrofurantoin Mono/Mac but then her leg started hurting after the 3rd dose of the Nitrofurantoin Mono/Mac, caller clarifies that she took 5 doses in total of the Nitrofurantoin Mono/Mac and then it started hurting with the leg. She went to urgent care on Saturday because she was still having it and they changed her antibiotic. She started the new antibiotic, she knew it was related since the leg pain was already going on when she started it on 14Aug2021, the new one is doing good, it's called Cefdinir 300mg. Caller wants to know if shingles can be a side effect of the vaccine. Caller wants to know if there is a need to delay in getting the second dose of the Pfizer BioNTech COVID19 vaccine or as scheduled since she got diagnosed with shingles. The outcome of the events shingles was recovered on an unspecified date; pain, UTI infection, joint pain, couldn't sleep, nerve pain, her leg started hurting after the first dose was not recovered; and Her leg is getting worse, rash came out, miserable was unknown.  No follow-up attempts are possible. No further information is expected.
I spoke with patient's daughter on 10/27/23. Patient experienced soreness at the injection site after the vaccination on 10/23/23. The next evening at 7 PM, Patient had difficulty breathing and coughed bl;ooded philegm. He was sent to hospital and put on ventilator. He had spike fever (105 degree), kidney and liver failure. He was deceased at 9:30 AM on 10/26/26 after he was taken off the ventilator.
This spontaneous case reported by a consumer, describes the occurrence of menopausal symptoms (menopausal women get their period out of the blue) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient had menopausal symptoms (menopausal women get their period out of the blue). At the time of the report, menopausal symptoms (menopausal women get their period out of the blue) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No medical history, concomitant or treatment information provided.
Headache; This spontaneous case was reported by an other health care professional and describes the occurrence of HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.
Muscle pain that does not seem to go away. At a point it appeared to radiate towards my left elbow from the upper part of left arm where it was admin.  I also feel a bit of pain when I try to lift up my left arm
Information has been received for Merck Pregnancy Registry for Gardasil from a mother of a nineteen year old patient witno allergies, inflammation of appendix, cholecystitis "needed to go out", and spleen disorder.  She also had a history of infectious mononucleosis in September 2007.  The patient received a first dose of Gardasil on an unspecified day and on 31-OCT-2007 she received the second injection.  Concomitant therapy included PRENATE, ferrous sulfate, children's vitamins (unspecified) and iron supplement (unspecified).  It was reported that PRENATE and ferrous sulfate were discontinued since it upset her stomach (no date for start and stop of therapy reported).  The reporter reported that her daughter got pregnant after she received the injection.  She had been to the emergency room four times because of dehydration.  She experienced pregnancy related nausea.  Patient also experienced abdominal pain and had a urine beta-human chorionic gonadotropin test (PAP) which caused some bleeding.  She was in the emergency room (E.R) on 13-MAR-2008 and was given morphine and intravenous (I.V) fluids.  Serum beta-human chorionic gonadotropin tests were done but result was not reported.  She had not needed hospitalization during this time.  No other information was available.  The outcome was unknown.  Additional information has been requested.  This is in follow-up to report(s) previously submitted on 4/14/2008. Additional information has been received from a Nurse who reported that the patient on 20-AUG-2008 had a healthy and normal baby. Additional information is not expected.
Arm pain, redness and swelling in left deltoid. Pain radiates away from injection site. No limit in mobility.
16SEP93 pt recvd vax; no crying when lt clinic; pt started crying inconsolably >3hrs in length; occasionally fell asleep for 10-15 mins & then resumed crying; different cry inc whiny funny high pitched; fussy; ? dec verbal development;
2 year old in good health had DTaP and IPV on 04/26. Re examined on 04/29 because of extreme irritibility, agitation and decreased sleep since the immunizations were given 3 days prior. No other explanation by HX or exam and suspect CNS irritablility to DTaP.
was supposed to receive adult Pfizer bivalent and was accidentally given undiluted Peds PFizer bivalent.  She has had no adverse effects per patient's husband
Monovalent mRNA vaccine administered for a bivalent mRNA dose.  I hadn't been made aware that the monovalent vaccine had had it's RA revoked by the FDA at the time of this vaccines administration..  My supervisor received e-mail notification from our county health department on 05/02/2023 with a update for immediate release to Covid-19 vaccines. This update simply stated that individuals that were previously vaccinated with monovalent Covid-19 vaccines and who had not received a dose of Bivalent vaccine could receive a single dose of bivalent vaccine.   The press release/ immediate release (dated 05/01/2023) did NOT state that the RA had been revoked  on 04/18/2023.  I received the e-mail forwarded to me  on 05/03/2023 which I then destroyed the remaining MDV of Pfizer monovalent Lot FP7136 vaccine.   This patient did NOT suffer any type of adverse reaction or event.    This patient was notified of this occurrence but declined  the bivalent vaccine when offered.   This patient was released from our custody and extradited to County Sheriff Office, on 05/11/2023.
Records indicate she was given an expired vaccine. However, it is unclear if that is the case or if it was just documented incorrectly. The EHR at the time auto-populated with dates and lot numbers and it is possible they were entered incorrectly. No known adverse event associated with it. She has had a Tdap since then and so I didn't not offer to revaccinate.
Pt states he had fever, cough, sleep problems, upset stomach, joint pain, fatigue all bad enough to go & see his physician.
Pupil dilated, eye red.  Initial report received on 24 October 2006 from a health care professional.  A 30 year-old female patient, with a medical history of allergies, had received an intramuscular, right deltoid injection of Fluzone SV 2006-2007, on 23 October 2006.  There was no illness at the time of vaccination, and the patient was on no other medications.  The next day, she developed a red and dilated eye.  It was not specified which eye was effected.  The patient had not yet seen a physician.  The patient had not recovered.